Ekso Bionics Holdings Income Statement (2012-2026) | EKSO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	2.21M	3.05M	4.08M	2.57M	3.33M	3.33M	3.55M	4.12M	4.70M	4.61M	4.85M	3.76M	4.95M	4.13M	5.09M	3.38M	2.06M	4.23M	3.14M	2.14M
Cost of Revenue (Quarter)	0.92M	1.24M	4.47M	1.36M	1.82M	1.74M	2.33M	2.12M	2.45M	2.05M	1.98M	1.80M	1.85M	1.92M	2.99M	1.71M	1.24M	1.68M	2.44M	1.07M
Gross Profit (Quarter)	1.29M	1.81M	2.42M	1.21M	1.64M	1.69M	1.68M	2.00M	2.25M	2.46M	2.37M	1.95M	2.64M	2.21M	2.71M	1.81M	0.82M	2.55M	1.67M	1.07M
Operating items
Amortization - Intangibles (Quarter)																0.08M				0.08M
Research & Development (Quarter)																				0.58M
Selling, General & Administrative (Quarter)																				4.06M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)																				2.05M
Operating Expenses (Quarter)																				6.69M
Operating Income (Quarter)																				-5.62M
EBIT (Quarter)																				-5.62M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)																				-0.24M
Non Operating Income (Quarter)																				-0.01M
Net income details
EBT (Quarter)																				-5.76M
Tax Provisions (Quarter)
Profit After Tax (Quarter)																				-6.88M
Income from Continuing Operations (Quarter)																				-5.76M
Consolidated Net Income (Quarter)																				-5.76M
Income towards Parent Company (Quarter)																				-5.76M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)																				-5.76M
Additional items
EPS (Basic) (Quarter)																				-2.04
EPS (Weighted Average and Diluted) (Quarter)	-0.11	-0.17	-0.26	-0.36	-0.23	-0.33	-0.24	-0.33
Shares Outstanding (Weighted Average) (Quarter)																				3.56M
Shares Outstanding (Diluted Average) (Quarter)	12.74M	12.71M	12.27M	12.73M	12.88M	13.07M	12.96M	13.30M
EBITDA (Quarter)																				-6.67M
Interest Expenses (Quarter)																				0.14M
Tax Rate (Quarter)

Research Tools

Ekso Bionics Holdings Income Statement (2012-2026) | EKSO

Create an account

Sign In

Reset Password